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Abstract
Purpose To compare the coronary atherosclerotic burden in
patients with and without type-2 diabetes using CT
Coronary Angiography (CTCA).
Methods and Materials 147 diabetic (mean age: 65±
10 years; male: 89) and 979 nondiabetic patients (mean
age: 61±13 years; male: 567) without a history of coronary
artery disease (CAD) underwent CTCA. The per-patient
number of diseased coronary segments was determined and
each diseased segment was classified as showing obstruc-
tive lesion (luminal narrowing >50%) or not. Coronary
calcium scoring (CCS) was assessed too.
Results Diabetics showed a higher number of diseased
segments (4.1±4.2 vs. 2.1±3.0; p<0.0001); a higher rate
of CCS>400 (p<0.001), obstructive CAD (37% vs. 18%
of patients; p<0.0001), and fewer normal coronary arteries
(20% vs. 42%; p<0.0001), as compared to nondiabetics.
The percentage of patients with obstructive CAD paral-
leled increasing CCS in both groups. Diabetics with
CCS≤10 had a higher prevalence of coronary plaque
(39.6% vs. 24.5%, p=0.003) and obstructive CAD (12.5%
vs. 3.8%, p=0.01). Among patients with CCS≤10 all
diabetics with obstructive CAD had a zero CCS and one
patient was asymptomatic.
Conclusions Diabetes was associated with higher coronary
plaque burden. The present study demonstrates that the
absence of coronary calcification does not exclude obstruc-
tive CAD especially in diabetics.
Keywords Diabetes mellitus . Coronary artery disease .
CT coronary angiography
Introduction
Over the past decades type-2 diabetes mellitus (DM) has
become a major public health concern. The World Health
Organization estimates that worldwide 220 million people
have diabetes, a number that may double by the year 2030
[1]. Diabetic patients have a higher prevalence of coronary
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heart disease and are more likely to develop myocardial
infarction compared to those without diabetes. The risk of
myocardial infarction or coronary death in type 2 diabetics
is similar to patients with a history of myocardial infarction
[2]. Frequently, diabetic patients with objective coronary
heart disease have blunted or atypical symptoms, thought to
be related to autonomic denervation of the heart [3].
Non-enhanced, ECG-synchronized CT imaging of the
heart can image calcified atherosclerotic plaque in the
coronary arteries [4, 5]. The amount of coronary calcium on
CT, which correlates with the global coronary plaque
burden [6], was demonstrated to be significantly higher in
diabetic patients, reflecting the higher prevalence of (pre-
clinical) coronary atherosclerosis [7, 8]. More recently
contrast-enhanced CT coronary angiography (CTCA) has
emerged as a non-invasive means to diagnose coronary
artery stenosis [9]. As CTCA also visualizes non-calcified
plaque in addition to calcified plaque material in the vessel
wall, contrast-enhanced CT allows more complete evalua-
tion of the total plaque burden [10].
In this cross-sectional study we compared the presence
of obstructive and non-obstructive CAD as well as calcified
coronary artery plaque burden in a total of 1126 patients
with and without diabetes mellitus.
Material and methods
Population
Over a 2-year period 1126 consecutive patients with
suspected CAD but no history of coronary artery disease
(prior myocardial infarction or myocardial revasculariza-
tion procedure) underwent CTCA at our institute. The
study was a single-centre prospective observational study.
Reasons for referral included angina, high-risk profile
without symptoms or nonconclusive stress test results.
Detailed information regarding symptoms, physical exam-
ination, medical history and risk factors were collected
prospectively at the time of presentation. The population
included 147 patients (13%) with diabetes, defined as a
fasting plasma glucose level of ≥ 126 mg/dL treated either
by dietary intervention, oral glucose-lowering medication
or insulin [11]. Chest pain symptoms were classified as
typical, atypical and non-anginal, according to the criteria
by Diamond & Forrester [12]. The category “other
sympoms” included dyspnea.
Pre-test likelihood of CAD was determined in every
patient according to a modification of the Diamond-
Forrester algorithm, as published by Morise et al. [13].
These patients were further categorized into low probability
(score 0–8), intermediate probability (score 9–15), and high
probability (score >15).
Patients only underwent CTCA in the absence of an
irregular heart rate, pregnancy, a known contrast allergy or
renal insufficiency (creatinine clearance <60 mL/min),
respiratory conditions preventing a 12 s breath hold, or
unstable clinical conditions. The study was approved by the
Medical Ethics Committee and informed consent was
obtained from all participating patients before testing.
CT coronary angiography
All examinations were performed using 64-slice CT
(Sensation 64, Siemens, Forchheim, Germany). To assess
the coronary calcium burden, non-enhanced ECG-triggered
CT was performed: collimation 20×1.2 mm, 120 kV,
150 mAs, estimated dose 1.5 mSv.
All examinations were performed using 64-slice CT
(Sensation 64, Siemens, Forchheim, Germany). A coronary
calcium score (CCS) was calculated according to the Agatston
method [14] using semiautomatic software available on the
workstation (Siemens HeartView, Forchheim, Germany).
CT coronary angiography was performed using a
retrospectively ECG-gated protocol with ECG-controlled
tube current modulation: collimation 64(32×2)×0.6 mm,
120 kV, 800–950 mAs, rotations time 0.33 s, estimated
radiation dose 8–13 mSv, after injection of 80–100 ml of
iomeprol 400 mgI/ml (Iomeron, Bracco, Italy) at 4–6 ml/s,
using automatic bolus tracking to synchronize CT data
acquisition with the passage of the contrast medium.
Images were reconstructed during mid-diastole and/or
end-systole: slice thickness 0.75 mm, reconstruction inter-
val 0.4 mm, medium smooth filtering (B30f). In the
absence of contra-indications 5–10 mg atenolol was
intravenously administrated to patients with a heart rate
>65/min. All received sublingual nitroglycerin (0.3 mg) just
before the scan.
Two independent, observers, blinded with regard to the
patients’ clinical background, evaluated all CT angiograms,
with disagreeing results resolved in a joint consensus reading.
Each of 16 coronary segments [15] was first assessed for
image quality and interpretability. Per interpretable coronary
segments the presence of atherosclerotic plaque, defined as
structures ≥1 mm in diameter within the vessel wall adjacent
to the coronary artery lumen but distinguishable from the
perivascular tissues, was assessed using axial images and
multiplanar reformations [4]. The segmental stenosis severity
was visually estimated and classified as obstructive (>50%
luminal diameter narrowing) or non-obstructive (≤50%
luminal narrowing).
Statistical analysis
Categorical variables are described as frequencies (percent-
age), continuous variables as mean (± SD) or median
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(interquartile range) respectively for normally and not
normally distributed variables. Groups were compared using
the Student t and Chi-square or Fisher exact tests, as
appropriate. Because coronary artery calcium score had
highly skewed, non-normal distributions, the Mann–Whitney
U test was used to compare coronary artery calcium scores
between diabetic and nondiabetic subjects.
To assess the range and the severity of CAC burden,
patients were divided into five categories, as previously
reported [16]: less than or equal to 10 (negative or minimal
CCS), 11–100 (mild CCS), 101–400 (moderate CCS), 401–
1000 (severe CCS), and greater than 1000 (extensive CCS).
Furthermore, the relationship between the calcium score
stratified in three groups (0–10, 11–100, >100) and
coronary artery disease on CTCA was assessed.
To determine the association between CTCA variables
and the presence of diabetes, linear regression analysis was
performed for continuous dependent variables, logistic
regression analysis for categorical dependent variables.
Univariate analysis was followed by multivariate analysis
with adjustment for: age, gender, traditional risk factors for
CAD (hypertension, hypercholesterolemia, obesity, family
history of CAD, smoking) and symptoms (typical angina,
atypical angina and other symptoms). A forward stepwise
multiple linear or logistic regression analysis was used,
with a required variable significance of 0.05 to be included
into the model, and a cut-off value of 0.1 for exclusion.
Variables with a significance below 0.05 in the final model
were included in this model. Odds ratios or estimates of
correlation were estimated with a 95% confidence intervals.
Statistical analysis was performed with dedicated software
(SPSS 12.0, SPSS Inc., USA).
Results
Patient characteristics
CTCA was performed without complications in all 1126
patients: 58% male, 61±13 years (Table 1). Overall, 165
(15%) patients had low, 609 (54%) had intermediate, and
352 (31%) had high pre-test likelihood of CAD. Diabetic
patients were older (65±11 years vs. 61±13 years, p=
0.0003), had a higher BMI (28.7 vs. 26.5, p<0.0001),
compared to non-diabetics, as well as a larger number of
traditional risk factors; 2.4 versus 1.9, including hyperten-
sion, hypercholesterolemia and obesity, in addition to
diabetes mellitus. Diabetic subjects who underwent a
functional stress test before CTCA, such as exercise
treadmill or pharmacological stress imaging testing (myo-
cardial perfusion imaging and stress echocardiography),
showed a higher rate of non-conclusive test results
compared to non-diabetics: 39% (n=33/85) vs. 26% (n=
162/620), p=0.02.
All patients Diabetics Non-diabetics p Valuea
(n=1126) (n=147) (n=979)
Clinical characteristics
Age (years; mean±SD) 61.4±12.6 64.9±10.5 60.9±12.8 0.0003
Male gender (%) 656 (58) 89 (60) 567 (58) 0.6
BMI (kg/m²; mean±SD) 26.8±4.3 28.7±4.4 26.5±4.2 <0.0001
Mean heart rate (min−1±SD) 62.6±11.8 63.6±12.4 62.5±11.7 0.29
Risk factors
Number of risk factors (mean±SD) 2.0±1.2 2.4±1.2 1.9±1.2 <0.0001
Hypertension (%) 671 (60) 105 (71) 566 (58) 0.002
Hypercholesterolemia (%) 484 (43) 76 (52) 408 (42) 0.027
Obesity (BMI≥30 kg/m²) (%) 231 (20) 54 (37) 177 (18) <0.0001
Current smoking (%) 356 (32) 50 (34) 306 (31) 0.56
Family history of coronary disease (%) 530 (47) 69 (47) 461 (47) 0.95
Symptoms
Typical angina pectoris (%) 271 (24) 26 (18) 240 (25) 0.08
Atypical angina pectoris (%) 335 (30) 47 (32) 288 (29) 0.59
Non-anginal or other symptoms (%) 224 (20) 43 (29) 186 (19) 0.005
Asymptomatic (%) 296 (26) 31 (21) 265 (27) 0.15
Pre-test likelihood of CADb
Low (%) 165 (15) 5 (3) 160 (16) 0.0001
Intermediate (%) 609 (54) 62 (42) 547 (56) 0.002
High (%) 352 (31) 80 (54) 272 (28) <0.0001
Table 1 Baseline characteristics
Data are presented as number
(percentage) of subjects or the
mean value±SD. Body-mass
index (BMI). a Variables were
compared between diabetic and
non-diabetic patients using the
independent samples t test and
Pearson’s chi-square test, as
appropriate. b According to the
scoring method of Morise.
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Furthermore, diabetics more frequently presented with
non-anginal or other symptoms such as dyspnea respect to
nondiabetics (29% vs. 19%, p=0.005). The mean heart rate
during the scan was 63±12 bpm, and not different between
patients with and without diabetes (p>0.05).
Coronary plaque and stenosis
For CTCA diagnostic image quality was achieved in
16,907 out of 17,017 coronary segments (99.4%). Image
quality was considered non-diagnostic in 110 (0.6%)
segments: 91 related to motion artefacts, 19 to severe
calcification, which were excluded from further evalua-
tion (Table 2, Figs. 1 and 2). Diabetics had a higher
prevalence of any coronary artery atherosclerosis (per-
patient) compared to non-diabetics: 80% (n=118), vs. 58%
(n=567), respectively (p<0.0001); and a higher preva-
lence of obstructive coronary disease: 37% (n=55), vs.
18% (n=173), respectively, p<0.0001 (Fig. 1). Per patient
the number of segments with plaque was higher for those
with diabetes: 4.1 vs. 2.1, respectively (p<0.0001); as
well as the number of segments with obstructive disease:
0.8 vs. 0.4, respectively, p=0.0001 (Fig. 2). Multivessel
disease was seen more often in patients with diabetes: 15%
(n=22), vs. 7% (n=62), respectively (p=0.0004) (Table 2).
Prevalence of non-obstructive and obstructive CAD on
CTCA in DM and non DM patients stratified for the type
of presenting symptom are provided in Table 3. In both
DM and non DM patients, the higher prevalence of
obstructive CAD was documented in patients with typical
angina (46% vs. 28%, respectively, p=n.s.). Moreover,
diabetics compared to nondiabetics showed an higher
prevalence of obstructive CAD among the other clinical
categories.
Coronary calcium
The median Agatston calcium score was higher in
diabetic patients: 124.4 (interquartile range: 0-658.8),
versus 0 (interquartile range: 0-112.8), respectively, (p<
0.0001). Only 29% (n=43) of the diabetics, compared to
47% (n=458) of the non-diabetics had a negative calcium
score (p=0.0001). Furthermore, only 4% (n=5) of dia-
betics vs 9% (n=88) of non-diabetics showed minimal
CCS (1–10), p=0.03. Consequently, higher calcium scores
(>400) were more prevalent among diabetic patients
respect to non-diabetics (n=50/147, 34% vs n=108/979,
11%, p<0.0001), (Fig. 3). For patients with a low or
negative calcium score (≤10), CTCA shows that those
with diabetes had a higher prevalence of coronary
atherosclerosis: 39.6% (n=19/48) vs. 24.5% (n=134/
546), p=0.003, as well as more obstructive CAD: 12.5%
(n=6/48) vs. 3.8% (n=21/546), p=0.01, compared to non-
diabetics (Fig. 4). Notably, among patients with CCS
from 0 to 10, all 6 diabetic subjects (100%) with
obstructive CAD on CTCA had negative CCS, whereas
only 43% (n=9/21) of non-diabetics with obstructive
CAD had CCS=0. Correspondingly, among patients with
negative CCS, 14% of diabetics (n=6/43) and 2% of non-
diabetics (n=9/458) showed obstructive CAD, p<0.0001.
Furthermore, after stratification by presenting symptoms,
diabetic patients with negative CCS and typical pain
showed a higher prevalence of non-obstructive (non-
calcific) CAD respect to non-diabetics: 50% (n=4/8) vs
10% (n=10/97), p<0.05 (Table 4). Although diabetics
with CCS=0 showed a trend towards higher prevalence
of obstructive CAD among symptom categories, not
statistically significant differences between groups were
observed.
Diabetics Nondiabetics p Valuea
(n=147) (n=979)
Patients
Normal coronary arteries (%) 29 (20) 412 (42) <0.0001
Non-obstructive atherosclerosis (%) 63 (43) 394 (40) 0.6
Coronary stenosis (%) 55 (37) 173 (18) <0.0001
Single-vessel disease (%) 33 (22) 111 (11) 0.0003
Multivessel disease (%) 22 (15) 62 (7) 0.0004
Calcium score
mean±SD 437.4±636.03 161.6±420.26 <0.0001
median (IQR) 124.4 (0–658.8) 3 (0–112.8) <0.0001
Coronary segments
Atherosclerotic (mean±SD]) 4.1±4.18 2.1±3.03 <0.0001
Non stenotic (mean [SD]) 3.3±3.71 1.7±2.59 <0.0001
Stenotic (mean [SD]) 0.8±1.48 0.4±1.08 0.0001
Table 2 CTCA findings
in patients with and without
diabetes
a Diabetic and nondiabetic patients
were compared using the Pearson’s
chi-square test (for percentages),
independent samples t test (for
mean CAC score), and Mann–
Whitney U test (for median CAC
score). Data are presented as num-
ber (percentage) of subjects, the
mean value±SD or median value
(IQR: interquartile range).
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Finally, patients with a high calcium score had more
obstructive CAD for both diabetics and non-diabetics,
without any significant differences between the two groups
(Fig. 4).
Association between CT coronary disease and diabetes
mellitus
By univariate regression analysis having diabetes was
associated with more atherosclerotic plaque, coronary
stenosis (per coronary branch), single and multi-vessel
disease, higher coronary calcium score, and for patients
with a negative or minimal CCS (≤10) with the presence of
any atherosclerotic plaque or obstruction, as well as the
presence of plaque and obstruction per coronary segments
(p<0.05) (Table 5). After adjusting for baseline character-
istics: age, gender, traditional risk factors for CAD
(hypertension, hypercholesterolemia, obesity, family history
of CAD, smoking) and symptoms (typical angina, atypical
angina and other symptoms), forward stepwise multivariate
regression analysis confirmed that all of these variables,
except obstructive CAD in the LCX, were independently
associated with diabetes.
Discussion
CT coronary disease and diabetes
An ageing population, suboptimal nutritional habits and
increased prevalence of obesity will increase the prevalence
of type II diabetes and related health problems, including
coronary heart disease [1, 17]. Indeed in our study patients
with diabetes had a significantly higher calcium score
compared to non-diabetics. In addition the number of
segments per patient with coronary plaque on CTCA was
nearly twice as high for diabetic patients, similarly the
number of segments with obstructive disease was two times
higher compared to patients without diabetes. In the current
study with CTCA, coronary atherosclerosis was observed in
80% of diabetics and almost half showed obstructive CAD.
These results are in line with previous observations derived
from a large autopsy cohort of 293 diabetic decedents, in
which coronary atherosclerosis was observed in almost
75% of individuals, with 50% having diffuse multi-vessel
CAD [18].
In both diabetic and non-diabetic patients, the higher
prevalence of obstructive CAD was documented in patients
with typical angina. This finding is in agreement with the
seminal work by Diamond and Forrester [19], in which
patients with typical angina had a higher likelihood of
angiographic CAD than patients with atypical or non-
anginal chest pain. Moreover, among the other clinical
categories, diabetics showed a two to three times higher
prevalence of obstructive CAD as compared to non-
diabetics. These results seem to reflect that the prevalence
of obstructive CAD is less influenced by symptomatic
status in diabetics respect to non-diabetics.
At multiple regression analysis, the increased extent and
severity of CAD associated with diabetes was independent
of traditional risk factors of cardiovascular disease, which
confirms earlier studies in asymptomatic populations [20,
21] as well as symptomatic populations [22–24].
Fig. 2 Segmental coronary artery disease in patients with and without
diabetes mellitus. Clustered multiple-variable graph of the number of
segments per patient with coronary atherosclerosis, divided in non-
obstructive plaque and obstructive coronary disease, for patients with ( )
and without diabetes mellitus (□)
Fig. 1 Prevalence of coronary artery disease (CAD) in patients with
and without diabetes mellitus. Per patient prevalence of the absence of
detectable CAD (p<0.0001), obstructive disease (p<0.0001), and
non-obstructive CAD (p>0.05)
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CT coronary angiography and calcium score in diabetic
patients with suspected coronary artery disease
The assessment of suspected coronary heart disease is more
challenging in diabetic patients because of the atypical
nature or absence of chest pain symptoms, more frequent
inability to perform an exercise tests and less reliable stress
imaging in the presence of obesity or multivessel disease
[25, 26]. Moreover, among the patients referred after a non-
conclusive stress test, diabetic patients were overrepresent-
ed. CT coronary angiography is considered complementary
to stress testing, and for the mentioned reasons may be
particularly useful in diabetic patients. While it lacks the
diagnostic and prognostic value of the aerobic performance,
it adds value in terms of (non-obstructive) plaque imaging.
However, the higher calcium may complicate severity
assessment of individual lesions.
Since calcium deposition is related to the presence of
atherosclerosis, coronary calcifications serve as a direct
marker for CAD, and more severe plaques tend to have a
greater amount of calcium [27]. In our population-based
study, about half of the patients in both groups with CCS
>100 had obstructive CAD. Furthermore, extensive CCS
(>400) was more prevalent in diabetic patients than non-
diabetic control subjects (34% vs 11%). These findings are
of interest, as a calcium score higher than 400 is
associated with a high risk of myocardial perfusion
impairment [28] and a high risk of any cardiovascular
event in the short term [29]. Nevertheless, as recently
pointed out [30], it remains important to recognise that for
any extent of plaque burden, cardiovascular risk is higher
in diabetic patients than in nondiabetic individuals.
The exact prevalence of noncalcified plaque in the
absence of any calcium remains to be fully elucidated;
previous studies have shown a large variation, which may
be explained by differences in study population [31]. In our
study we observed a higher rate of plaques and three times
more frequent obstructive disease (12.5% vs 3.8%, p=0.01)
in diabetic population respect to non-diabetics despite a
negative/low calcium score. Previous observations using
64-slice CTCA in patients with stable chest pain syndrome
or with suspected acute coronary syndrome (regardless of
the presence of diabetes) reported a prevalence of obstruc-
tive CAD with zero and low CCS in the range of 6.2–10%
[32–35]. A recent prospective multicenter trial including
mainly intermediate-risk patients with suspected CAD and
planned clinically-indicated conventional coronary angiog-
raphy within 30-day from 64-slice CTCA examination,
reported a prevalence of 19% of obstructive CAD among
patients with CCS=0 [36]. Taken together these observa-
tions suggest that the absence of coronary calcium does not
reliably exclude atherosclerosis or even obstructive CAD in
Fig. 4 Association between the coronary calcium score and coronary
artery disease on CTCA. Clustered bar graph of the CTCA findings:
normal coronary arteries (□), non-obstructive CAD ( ), and
obstructive CAD (■), for patients with (DM+) and without diabetes
mellitus (DM-), divided into three groups according to the coronary
calcium score (CCS). *=significant differences between diabetics and
non-diabetics (p<0.05)
Fig. 3 Coronary calcium score distribution in relation to diabetes
mellitus. Bar graph of the distribution of coronary calcium score (CCS)
categories for patients with ( ) and without diabetes mellitus (□)
Table 3 Prevalence of non-obstructive CAD/obstructive CAD in diabetic and non-diabetic patients among different symptom categories
Symptom categories Diabetics (n=147) Nondiabetics (n=979)
Typical angina pectoris 12/26 (46)/12/26 (46) 88/240 (37)/68/240 (28)
Atypical angina pectoris 21/47 (45)/16/47 (34)* 126/288 (44)/35/288 (12)*
Non-anginal or other symptoms 16/43 (37)/16/43 (37)* 72/186 (39)/33/186 (18)*
Asymptomatic 14/31 (45)/11/31 (35)* 108/265 (41)/37/265 (14)*
Data are presented as number/total number (percentage) of subjects.
*Significant difference (p<0.05) between diabetic and non-diabetic patients.
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patients at high cardiovascular risk and this may be
especially true for diabetic subjects.
Detection of preclinical coronary artery disease
Diabetic patients have a much higher risk of cardiovascular
events, which qualifies them for intensive preventive man-
agement. Considering this high risk of adverse events and
stunned anginal symptoms in the presence of obstructive
CAD, raises the question whether early detection of CAD is
meaningful in diabetics. In the current study, we documented
obstructive CAD in one asymptomatic patient with CCS=0
(1/7, 14%); this observation is in concordance with the study
of Sholte et al. which reported a prevalence of obstructive
CAD in 10% of asymptomatic diabetic patients with minimal
calcium (CCS<10) [20]. Further risk refinement by various
non-invasive means has proven difficult. Clinical outcome
after a negative stress echocardiography test or myocardial
perfusion scan is not equally favourable in diabetic patients,
and does not have the same freedom-of-events warranty
duration, compared to patients without diabetes [37–39]. The
calcium score, which is associated with the total amount of
coronary atherosclerosis, predicts cardiovascular events both
in diabetic and non-diabetic patients, with incremental
predictive value to traditional risk factors [16]. CT angiog-
raphy provides a more complete representation of the total
plaque burden, i.e. imaging both calcified and non-calcified
plaque material, in addition to the detection and localization
Table 5 Association between CTCA findings and diabetes mellitus
CTCA characteristics Univariate Multivariateb
Parameter estimate p Value Parameter estimate p Value
Patients
Absence of CAD 0.34 (0.22–0.52) <0.0001 0.42 (0.26–0.68) <0.0001
Non-obstructive CAD 1.11 (0.78–1.58) 0.55 – –
Obstructive CAD 2.78 (1.92–4.04) <0.0001 2.44 (1.62–3.68) <0.0001
Single-vessel disease 2.15 (1.39–3.34) 0.001 1.85 (1.16–2.94) 0.01
Multivessel disease 2.46 (1.45–4.18) 0.001 2.08 (1.20–3.61) 0.009
Obstructive CAD in
LM/LAD coronary artery 2.45 (1.59–3.78) <0.0001 2.08 (1.32–3.28) 0.002
RCA 2.64 (1.63–4.25) <0.0001 2.25 (1.36–3.74) 0.002
LCX 1.87 (1.08–3.24) 0.03 – –
Total Agatston CSa 275.8 (197–354.6) <0.0001 228.3 (152.9–303.7) <0.0001
Overall CAD among patients with CCS≤10 2.03 (1.10–3.73) 0.02 1.98 (1.04–3.79) 0.04
Obstructive CAD among patients with CCS≤10 3.56 (1.36–9.31) 0.009 4.54 (1.63–12.6) 0.004
Segments
No. of diseased segmentsa 2.04 (1.49–2.6) <0.0001 1.6 (1.09–2.12) <0.0001
No. of segments with
obstructive plaquesa 0.45 (0.25–0.64) <0.0001 0.38 (0.18–0.57) <0.0001
nonobstructive plaquesa 1.6 (1.12–2.1) <0.0001 1.23 (0.78–1.69) <0.0001
Data are expressed as odd ratio (95% CI) or estimates of correlation (95% CI) when the dependent variable was respectively categorical or
continuous (a ). b After correction for baseline characteristics.
Table 4 Prevalence of non-obstructive CAD/obstructive CAD in diabetic and non-diabetic patients with CCS=0 among different symptom
categories
Symptom categories Diabetics (n=43) Nondiabetics (n=458)
Typical angina pectoris 4/8 (50)*/2/8 (25) 10/97 (10)*/5/97 (5)
Atypical angina pectoris 2/14 (14)/2/14 (14) 18/141 (13)/1/141 (1)
Non-anginal or other symptoms 2/14 (14)/1/14 (7) 8/90 (9)/2/90 (2)
Asymptomatic 0/7 (0)/1/7 (14) 13/130 (10)/1/130 (1)
Data are presented as number/total number (percentage) of subjects.
*Significant difference (p<0.05) between diabetic and non-diabetic patients.
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of obstructive disease. Preliminary data show that CTCA
adds prognostic information [40], and can perhaps identify
lesions that are more vulnerable to rupture [41]. Intuitively,
knowledge regarding the presence of severe (obstructive)
disease in the proximal coronary arteries should allow for
(even) more intensive management, better patient and
physician compliance, and perhaps improved outcome.
Whether this is true for symptomatic patients with or
without diabetes, and whether CTCA has incremental value
for risk re-assessment in the absence of symptoms, which is
currently not recommended, will need further study.
Study limitations
Interpretation of our results requires consideration of the
limitations related to registry data, particularly in terms of a
potential patient selection bias. While our results cannot be
extrapolated to the general diabetic and non-diabetic
population, they are hypothesis-generating and deserve
future exploration in a larger, multicenter study.
Furthermore, CTCA findings were not routinely con-
firmed by invasive coronary angiography, or intra-coronary
imaging techniques, although previous comparative studies
have shown good correlation of CTCA with invasive
angiography [42]. Detailed information concerning the
metabolic control of patients, secondary organ damage or
presence of autonomic dysfunction was unavailable.
Recent reports have even demonstrated the ability of
CTCA to detect differences in coronary plaque character-
istics between patients with and without DM [20–24].
However, characteristic of plaque composition has not been
evaluated in the present population-based study.
In addition, the remaining concern of CTCA regards
administration of contrast media and radiation exposure.
However, with recent advent of new generation CT
scanners and dose-modulation strategies, it will certainly
be possible to limit typical effective dose values for dual-
source CT and for single source CT in general to below
10 mSv and often to below 5 mSv [43].
Despite these limitations, the current study has the
strength of including a larger patient population with
respect to previous studies; further researches focused on
plaque morphology and composition and on the prognostic
importance of coronary stenosis are needed to better
understand the role of CTCA for risk stratification in both
diabetic and non-diabetic subjects.
Conclusion
CTCA in patients with diabetes and suspected CAD shows
significantly more plaque and obstructive disease compared
to patients without diabetes, which is independent of
presenting symptoms and traditional risk factors. Contrary
to non-diabetics, a low or negative calcium score does not
rule out obstructive coronary artery disease in patients with
diabetes mellitus.
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